Home > Resources > Whitepapers > The Transformation of Behavioral Health Care Begins in the ED

The Transformation of Behavioral Health Care Begins in the ED

May 10, 2018

The struggle to address the crisis in emergency psychiatry impacts patient safety, quality of care, hospital efficiency, and the bottom line. Industry leaders agree early intervention is critical. Since the vast majority of psychiatric emergencies resolve within 24 hours, hospitals can prevent unnecessary admission and enhance care by shifting to earlier intervention in the ED. This paper shares how today’s leaders are transforming EDs to address this population.

Spotlight

Memorial Health

Memorial University Medical Center (MUMC) is a non-profit, 530-bed tertiary care hospital in Savannah, Ga. We opened our doors in 1955 and have evolved into the most advanced healthcare provider in the region. We are a regional referral center for cardiac care, cancer care, trauma, pediatrics, high-risk obstetrics, and neonatology. Our hospital includes the region’s only Level 1 trauma center, the region’s only children’s hospital, and a state-of-the-art laboratory where scientists conduct research on the molecular genetics of cancer.

OTHER WHITEPAPERS

The 2022 Healthcare Cyber Trend Research Report

whitePaper | June 15, 2022

Infoblox is pleased to publish our 2022 Healthcare Cyber Trend Research Report. This report includes analysis of the major healthcare data breaches directly attributed to cyber attacks within the United States during calendar year 2021.

Increasing Health Equity in Your Community

whitePaper | November 12, 2022

The past two years have seen accelerated adoption and utilization of telehealth services by a majority of healthcare organizations, driven in large part by the COVID-19 pandemic.

Shifting the paradigm for ATMPs

whitePaper | January 14, 2022

Advanced Therapy Medicinal Products (ATMPs) are at the forefront of global scientific innovation in healthcare. These pioneering treatments, which include gene therapies, somatic cell therapies and tissue engineered products, have the potential to transform patients’ lives

Decentralised Clinical Trials In The Eu

whitePaper | March 23, 2023

DCTs can take a variety of forms depending on patients’ needs, study protocol, drug company preferences, or regulatory requirements. Trials may be remote and decentralised from start to finish with no physical contact between participants and investigators or they may rely on hybrid designs that incorporate only certain elements of decentralisatio

More Whitepapers

The Transformation of Behavioral Health Care Begins in the ED